208 related articles for article (PubMed ID: 6427340)
1. The antigen of mature human B cells detected by the monoclonal antibody FMC7: studies on the nature of the antigen and modulation of its expression.
Zola H; Moore HA; Hohmann A; Hunter IK; Nikoloutsopoulos A; Bradley J
J Immunol; 1984 Jul; 133(1):321-6. PubMed ID: 6427340
[TBL] [Abstract][Full Text] [Related]
2. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
3. Modulation of expression of the antigen identified by FMC7 upon human B-lymphocyte activation: evidence for differences between activation in vivo and in vitro.
Ferro LM; Zola H
Immunology; 1990 Mar; 69(3):373-8. PubMed ID: 2138127
[TBL] [Abstract][Full Text] [Related]
4. Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.
Zola H; McNamara PJ; Moore HA; Smart IJ; Brooks DA; Beckman IG; Bradley J
Clin Exp Immunol; 1983 Jun; 52(3):655-64. PubMed ID: 6191892
[TBL] [Abstract][Full Text] [Related]
5. A unique antigen on mature B cells defined by a monoclonal antibody.
Link MP; Bindl J; Meeker TC; Carswell C; Doss CA; Warnke RA; Levy R
J Immunol; 1986 Nov; 137(9):3013-8. PubMed ID: 3489782
[TBL] [Abstract][Full Text] [Related]
6. Identification of an early activation antigen (Bac-1) on human B cells.
Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
[TBL] [Abstract][Full Text] [Related]
7. Antibody-induced antigenic modulation is antigen dependent: characterization of 22 proteins on a malignant human B cell line.
Pesando JM; Hoffman P; Abed M
J Immunol; 1986 Dec; 137(11):3689-95. PubMed ID: 3491146
[TBL] [Abstract][Full Text] [Related]
8. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.
Sugimoto T; Sawada T; Negoro S; Kidowaki T; Morioka H; Matsumura T; Kemshead JT; Seeger RC
Cancer Res; 1985 Jan; 45(1):358-64. PubMed ID: 2981159
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
12. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
13. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
14. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
Miller RA; Gralow J
J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
[TBL] [Abstract][Full Text] [Related]
15. Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate.
Fraser JK; Berridge MV
Exp Hematol; 1987 May; 15(4):406-13. PubMed ID: 2952519
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
17. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.
Pezzutto A; Dörken B; Moldenhauer G; Clark EA
J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151
[TBL] [Abstract][Full Text] [Related]
18. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.
Brooks DA; Beckman IG; Bradley J; McNamara PJ; Thomas ME; Zola H
J Immunol; 1981 Apr; 126(4):1373-7. PubMed ID: 6970772
[TBL] [Abstract][Full Text] [Related]
19. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
20. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
